Liang Cao
Liang Cao
National Cancer Institute
Verified email at mail.nih.gov
Title
Cited by
Cited by
Year
A Method for Gene Disruption That Allows Repeated Use of URA3 Selection in the Construction of Multiply Disrupted Yeast Strains
E Alani, L Cao, N Kleckner
Genetics 116 (4), 541-545, 1987
10691987
A pathway for generation and processing of double-strand breaks during meiotic recombination in S. cerevisiae
L Cao, E Alani, N Kleckner
Cell 61 (6), 1089-1101, 1990
7741990
Temporal comparison of recombination and synaptonemal complex formation during meiosis in S. cerevisiae
R Padmore, L Cao, N Kleckner
Cell 66 (6), 1239-1256, 1991
5041991
Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F
L Cao, B Faha, M Dembski, LH Tsai, E Harlow, N Dyson
Nature 355 (6356), 176-179, 1992
4341992
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity
NS Azad, EM Posadas, VE Kwitkowski, SM Steinberg, L Jain, ...
Journal of Clinical Oncology 26 (22), 3709-3714, 2008
3552008
A phase II clinical trial of sorafenib in androgen-independent prostate cancer
WL Dahut, C Scripture, E Posadas, L Jain, JL Gulley, PM Arlen, JJ Wright, ...
Clinical cancer research 14 (1), 209-214, 2008
1972008
Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer
L Cao, Y Yu, S Bilke, RL Walker, LH Mayeenuddin, DO Azorsa, F Yang, ...
Cancer research 70 (16), 6497-6508, 2010
1932010
A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus
H Chen, L Hutt-Fletcher, L Cao, SD Hayward
Journal of virology 77 (7), 4139-4148, 2003
1912003
Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications
R Harouaka, Z Kang, SY Zheng, L Cao
Pharmacology & therapeutics 141 (2), 209-221, 2014
1862014
DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1
IO Ng, Z Liang, L Cao, TK Lee
Cancer research 60 (23), 6581-6584, 2000
1702000
Safety and clinical activity of the programmed death-ligand 1 inhibitor durvalumab in combination with poly (ADP-ribose) polymerase inhibitor olaparib or vascular endothelial …
JM Lee, A Cimino-Mathews, CJ Peer, A Zimmer, S Lipkowitz, ...
Journal of Clinical Oncology 35 (19), 2193, 2017
1672017
Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody
L Cao, Y Yu, I Darko, D Currier, LH Mayeenuddin, X Wan, C Khanna, ...
Cancer research 68 (19), 8039-8048, 2008
1622008
Phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGFβ, in advanced solid tumors
J Strauss, CR Heery, J Schlom, RA Madan, L Cao, Z Kang, E Lamping, ...
Clinical Cancer Research 24 (6), 1287-1295, 2018
1532018
Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors
G Giaccone, A Rajan, A Berman, RJ Kelly, E Szabo, A Lopez-Chavez, ...
Journal of clinical oncology 29 (15), 2052, 2011
1502011
Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)-and non-HIV-infected patients
SSY Wong, KH Wong, WT Hui, SS Lee, JYC Lo, L Cao, KY Yuen
Journal of clinical microbiology 39 (12), 4535-4540, 2001
1182001
MP1 encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei
L Cao, C Chan, C Lee, SS Wong, K Yuen
Infection and immunity 66 (3), 966-973, 1998
1141998
Crossover and noncrossover recombination during meiosis: timing and pathway relationships
A Storlazzi, L Xu, L Cao, N Kleckner
Proceedings of the National Academy of Sciences 92 (18), 8512-8516, 1995
1071995
Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial.
liang cao
103*
Nuclear factor-κB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts
Z He, B Xin, X Yang, C Chan, L Cao
Cancer research 60 (7), 1845-1848, 2000
992000
Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffeipenicilliosis
L Cao, DL Chen, C Lee, CM Chan, KM Chan, N Vanittanakom, ...
Journal of clinical microbiology 36 (10), 3028-3031, 1998
911998
The system can't perform the operation now. Try again later.
Articles 1–20